Supplement Dated April 27, 2015
To
Prospectuses Dated April 27, 2015
This supplement is intended for distribution with prospectuses dated April 27, 2015, or later, for variable life insurance contracts issued by John Hancock Life Insurance Company (U.S.A.) and John Hancock Life Insurance Company of New York, as applicable.
If your policy is titled
VUL Accumulator | VUL Protector | Survivorship VUL | ||
CVUL | Accumulation VUL | SPVL | ||
EPVUL | Majestic Performance VUL | Protection VUL |
Portfolio Annual Expenses
The Management Fees for the portfolios listed below have been revised to reflect a lower Management Fee and a reduction in the Total Operating Expenses.
Portfolio |
Management Fees | 12b-1 Fees | Other Expenses | Acquired Fund Fees and Expenses |
Total Operating Expenses |
|||||||||||||||
Financial Industries |
0.76 | % | 0.05 | % | 0.10 | % | 0.08 | % | 0.99 | % | ||||||||||
Fundamental Large Cap Value |
0.62 | % | 0.05 | % | 0.03 | % | 0.00 | % | 0.70 | % | ||||||||||
Health Sciences |
0.95 | % | 0.05 | % | 0.04 | % | 0.00 | % | 1.04 | % | ||||||||||
Small Cap Growth |
1.04 | % | 0.05 | % | 0.04 | % | 0.00 | % | 1.13 | % |
If your policy is titled
Medallion Executive Variable Life Medallion Executive Variable Life II |
Majestic Performance Survivorship Variable Universal Life | |
Medallion Executive Variable Life III | Protection Variable Universal Life | |
Majestic Variable Universal Life | Variable Estate Protection | |
Majestic Variable Universal Life 98 | Variable Estate Protection Plus | |
Variable Master Plan Plus | Variable Estate Protection Edge | |
Majestic Variable COLI | Performance Executive Variable Life | |
Majestic Variable Estate Protection | Performance Survivorship Variable Universal Life | |
Majestic Variable Estate Protection 98 Majestic Performance VUL |
Medallion Variable Universal Life Plus | |
Corporate VUL | Medallion Variable Universal Life Edge | |
Accumulation VUL Survivorship VUL |
Medallion Variable Universal Life Edge II Majestic Performance VUL |
Portfolio Annual Expenses
The Management Fees for the portfolios listed below have been revised to reflect a lower Management Fee and a reduction in the Total Operating Expenses.
Portfolio |
Management Fees | 12b-1 Fees | Other Expenses | Acquired Fund Fees and Expenses |
Total Operating Expenses |
|||||||||||||||
Financial Industries |
0.76 | % | 0.00 | % | 0.10 | % | 0.08 | % | 0.94 | % | ||||||||||
Fundamental Large Cap Value |
0.62 | % | 0.00 | % | 0.03 | % | 0.00 | % | 0.65 | % | ||||||||||
Health Sciences |
0.95 | % | 0.00 | % | 0.04 | % | 0.00 | % | 0.99 | % | ||||||||||
Small Cap Growth |
1.04 | % | 0.00 | % | 0.04 | % | 0.00 | % | 1.08 | % |
If your policy is titled eVariable Life, Flex V1, Flex V2 or Medallion Variable Life, we revise the Maximum expense disclosed in the following table in your prospectus, as follows:
Total Annual Portfolio Expenses
Total Annual Portfolio Operating Expenses |
Minimum | Maximum | ||||||
Range of expenses, including management fees, distribution and/or service (12b-1) fees, and other expenses.1 |
0.49 | % | 1.08 | % |
Portfolio Annual Expenses
The Management Fees for the portfolios listed below have been revised to reflect a lower Management Fee and a reduction in the Total Operating Expenses.
Portfolio |
Management Fees | 12b-1 Fees | Other Expenses | Acquired Fund Fees and Expenses |
Total Operating Expenses |
|||||||||||||||
Financial Industries |
0.76 | % | 0.00 | % | 0.10 | % | 0.08 | % | 0.94 | % | ||||||||||
Fundamental Large Cap Value |
0.62 | % | 0.00 | % | 0.03 | % | 0.00 | % | 0.65 | % | ||||||||||
Health Sciences |
0.95 | % | 0.00 | % | 0.04 | % | 0.00 | % | 0.99 | % | ||||||||||
Small Cap Growth |
1.04 | % | 0.00 | % | 0.04 | % | 0.00 | % | 1.08 | % |
You should read this supplement together with the prospectus for the contract you purchased, and retain both for future reference.
Prior to making any investment decisions, you should carefully review your product prospectus and all applicable supplements. In addition, you should review the prospectuses and applicable supplements for the underlying portfolios that we make available as investment options under the policies. The prospectuses describe the investment objectives, policies and restrictions of, and the risks relating to, investment in the portfolios. In the case of any of the portfolios that are operated as feeder funds, you should also review the prospectus for the corresponding master fund. If you need to obtain additional copies of any of these documents, please contact your representative or contact our Service Office at the address or telephone number on the back page of your product prospectus.
VLI ProdSupp VL2 5/2015
333-164150 |
333-164163 | 333-85284 | 333-127543 | 333-164175 | ||||
333-164151 |
333-164165 | 333-88748 | 333-131139 | 333-164176 | ||||
333-164152 |
333-164166 | 333-71136 | 333-131134 | 333-164158 | ||||
333-164153 |
333-164167 | 333-100597 | 333-132905 | 333-164159 | ||||
333-164156 |
333-164168 | 333-124150 | 333-157213 | 333-164160 | ||||
333-164155 |
333-164169 | 333-131299 | 333-85296 | |||||
333-164161 |
333-164170 | 333-157212 | 333-88972 | |||||
333-164162 |
333-164173 | 333-100567 | 333-33504 | |||||
333-164164 |
333-164174 | 333-126668 | 333-100664 | |||||
333-164154 |
333-164171 | 333-152406 | 333-152407 |